Akero Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Akero Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akero Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akero Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $630k | 27k | 23.35 |
| 2023-09-30 | $1.4M | 27k | 50.58 |
| 2023-06-30 | $1.1M | 24k | 46.69 |
| 2023-03-31 | $699k | 18k | 38.26 |
| 2022-12-31 | $1.0M | 18k | 54.80 |
| 2022-09-30 | $531k | 16k | 34.05 |
| 2022-06-30 | $147k | 16k | 9.45 |
| 2022-03-31 | $221k | 16k | 14.18 |
| 2021-12-31 | $208k | 9.8k | 21.16 |
| 2021-09-30 | $220k | 9.8k | 22.35 |
| 2021-06-30 | $244k | 9.8k | 24.82 |
| 2021-03-31 | $162k | 5.6k | 28.99 |
| 2020-12-31 | $144k | 5.6k | 25.76 |
| 2020-09-30 | $172k | 5.6k | 30.77 |
| 2020-06-30 | $139k | 5.6k | 24.87 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors